Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives

News

 14th December 2010 Society for Laboratory Automation and Screening

The First Annual SLAS China Conference & Exhibition Has Global Appeal

Newly Launched Event Sets Framework for Future SLAS Endeavors in Asia Pacific

CHICAGO – The newly merged Society for Laboratory Automation and Screening (SLAS) hosted its First Annual China Conference and Exhibition in Shanghai, China at the Shangri-La Hotel, 7-9 December – with resounding results.

With approximately 375 conference participants and 50 multi-national companies comprising the exhibition, the intensive three-day conference welcomed scientists, engineers, business professionals, and students from more than 20 countries. Seventy-five percent of the participants originated from Asia Pacific.

According to SLAS Scientific Program Committee Chair Steven Rees, GlaxoSmithKline, United Kingdom, the conference was “phenomenally successful.” Added Rees, “Bringing SLAS to Shanghai has demonstrated the interest and expertise in drug discovery in China, and the enthusiasm of the local scientists to partner with the SLAS community.”

The conference hosted 25 exclusive scientific lectures presented by world-renowned leaders in the field including such prominent individuals as Christopher Lipinski, Ph.D., Melior Discovery; Wei Zheng, Ph.D., NIH Chemical Genomics Center; and Sitta Sittampalam, Ph.D., University of Kansas Medical Center.

As an extra complimentary benefit to conference participants, SLAS partnered with the Shanghai Zhangjiang Technology Park for a private pre-event function highlighted by three additional scientific lectures and a guided tour of the technology park that houses 110 research and development institutions and 327 companies including the world’s leading pharmaceutical companies. The primary presentation was given by Xin Xie, Ph.D., Head of Assay Development, Chinese National Center for Drug Screening.

According to SLAS CEO Greg Dummer, “with the outstanding results of this first-of-its-kind event in China, it is clear we need to ramp-up our efforts to deploy a tangible plan for carrying forward our educational mission and serving our members in Asia Pacific. It is explicitly stated in our strategic vision, so it is gratifying to see the results of this inaugural conference. We’re moving in the right direction.”

Dummer expects to make a formal announcement regarding future SLAS endeavors in Asia Pacific in the first part of 2011.

For more information about SLAS and to view the SLAS Strategic Plan in its entirety, visit SLAS.org or call +1.877.990.SLAS (7527). In addition, the SLAS website offers members and nonmembers access and/or information about all society opportunities and initiatives.

# # #

The Society for Laboratory Automation and Screening (SLAS) is a new non-profit scientific organization uniting the former Society for Biomolecular Sciences (SBS) and the Association for Laboratory Automation (ALA). The SLAS mission is to be the preeminent global organization providing forums for education and information exchange, and to encourage the study of and improve the science and practice of laboratory automation and screening. For more information, please visit SLAS.org.


 

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |